Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GTHX will rise by +17.87% over the next 2 Weeks and hit $8.44 by Wednesday, October 2, 2024. In that time frame, GTHX's share price is expected to range between $7.39 and $9.50.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 2, 2024 | 7.44 | 8.44 | 9.46 |
| Oct 1, 2024 | 7.20 | 8.23 | 9.26 |
| Sep 30, 2024 | 7.17 | 8.17 | 9.21 |
| Sep 27, 2024 | 7.08 | 8.20 | 9.21 |
| Sep 26, 2024 | 7.18 | 8.22 | 9.24 |
| Sep 25, 2024 | 7.02 | 8.13 | 9.16 |
| Sep 24, 2024 | 6.99 | 7.93 | 8.92 |
| Sep 23, 2024 | 6.83 | 7.87 | 8.95 |
| Sep 20, 2024 | 6.83 | 7.89 | 8.95 |
| Sep 19, 2024 | 6.85 | 7.92 | 8.98 |
GTHX shares rose +0.14% in Tuesday, September 17, 2024's trading session, rising from a previous close of $7.15 to move at $7.16. The stock demonstrated notable intraday movement (see GTHX's key stats for a full breakdown), fluctuating between $7.14 and $7.16, a +0.28% trading range. While recent weeks have seen some volatility, GTHX has managed to secure a +0.42% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 0 shares changing hands, 1.27M fewer than the previous session. This amounted to $0.00 in total market activity.
Will GTHX Continue Its Upward Trend?
According to analyst ratings and projections for GTHX, G1 Therapeutics, Inc. shares are anticipated to increase by +24.28%, potentially reaching $9.46 per share by October 2, 2024. Short-term technical indicators currently suggest a neutral sentiment for GTHX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the GTHX stock forecast, now is a good time to buy GTHX stock because its current trading price is -15.16% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on GTHX covering social and institutional perspectives.
GTHX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GTHX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 81.57% to 84.39%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 68.76%, suggests strong medium-term momentum. However, the 100-day RSI, at 60.65%, points to growing bullish momentum over the long term. Insights into GTHX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
G1 Therapeutics, Inc. Monthly Forecast 2024–2025
September 2024
According to our latest forecast models, G1 Therapeutics, Inc. (GTHX) is positioned to show a strong performance in September 2024. The price is predicted to move between $13.51 and $14.71, settling at an average of $14.22. This could translate to a +98.60% gain.
October 2024
Based on current market signals, G1 Therapeutics, Inc. is projected to trend october 2024. We forecast a trading range from $11.71 to $14.84, with a likely average price of $13.26. Investors could expect a potential return of +85.20%.
November 2024
Our predictive algorithms indicate G1 Therapeutics, Inc. stock may see a shift in November 2024. The expected range spans $9.46–$15.22, with an average target of $13.01. This represents a positive outlook and a possible gain of +81.70%.
December 2024
Analyzing established trends, G1 Therapeutics, Inc. looks set to move in December 2024. Projections place the stock between $8.73 and $15.04, averaging around $10.60. This suggests a +48.04% gain from current levels.
January 2025
Market indicators suggest G1 Therapeutics, Inc. could experience notable changes during January 2025. Prices could fluctuate within $14.06 to $26.51, with a midpoint forecast of $20.68. The stock might deliver a +188.83% gain.
February 2025
Forecasting for February 2025, models estimate that G1 Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $21.43 and $27.80, averaging $25.53. This signals a positive trajectory with potential returns around +256.56%.
March 2025
According to our latest forecast models, G1 Therapeutics, Inc. (GTHX) is positioned to show a strong performance in March 2025. The price is predicted to move between $18.87 and $26.44, settling at an average of $23.20. This could translate to a +224.02% gain.
April 2025
Based on current market signals, G1 Therapeutics, Inc. is projected to trend april 2025. We forecast a trading range from $11.41 to $25.70, with a likely average price of $19.47. Investors could expect a potential return of +171.93%.
May 2025
Our predictive algorithms indicate G1 Therapeutics, Inc. stock may see a shift in May 2025. The expected range spans $9.89–$18.99, with an average target of $13.67. This represents a positive outlook and a possible gain of +90.92%.
June 2025
Analyzing established trends, G1 Therapeutics, Inc. looks set to move in June 2025. Projections place the stock between $13.00 and $29.15, averaging around $19.29. This suggests a +169.41% gain from current levels.
July 2025
Market indicators suggest G1 Therapeutics, Inc. could experience notable changes during July 2025. Prices could fluctuate within $17.88 to $37.91, with a midpoint forecast of $26.61. The stock might deliver a +271.65% gain.
August 2025
Forecasting for August 2025, models estimate that G1 Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $21.55 and $44.82, averaging $30.96. This signals a positive trajectory with potential returns around +332.40%.
September 2025
According to our latest forecast models, G1 Therapeutics, Inc. (GTHX) is positioned to show a strong performance in September 2025. The price is predicted to move between $19.42 and $44.35, settling at an average of $30.40. This could translate to a +324.58% gain.
GTHX's history of dividends and stock splits also plays a role in long-term investor confidence.